Literature DB >> 34617025

Synthesizing High-b-Value Diffusion-weighted Imaging of the Prostate Using Generative Adversarial Networks.

Lei Hu1, Da-Wei Zhou1, Yun-Fei Zha1, Liang Li1, Huan He1, Wen-Hao Xu1, Li Qian1, Yi-Kun Zhang1, Cai-Xia Fu1, Hui Hu1, Jun-Gong Zhao1.   

Abstract

PURPOSE: To develop and evaluate a diffusion-weighted imaging (DWI) deep learning framework based on the generative adversarial network (GAN) to generate synthetic high-b-value (b =1500 sec/mm2) DWI (SYNb1500) sets from acquired standard-b-value (b = 800 sec/mm2) DWI (ACQb800) and acquired standard-b-value (b = 1000 sec/mm2) DWI (ACQb1000) sets.
MATERIALS AND METHODS: This retrospective multicenter study included 395 patients who underwent prostate multiparametric MRI. This cohort was split into internal training (96 patients) and external testing (299 patients) datasets. To create SYNb1500 sets from ACQb800 and ACQb1000 sets, a deep learning model based on GAN (M0) was developed by using the internal dataset. M0 was trained and compared with a conventional model based on the cycle GAN (Mcyc). M0 was further optimized by using denoising and edge-enhancement techniques (optimized version of the M0 [Opt-M0]). The SYNb1500 sets were synthesized by using the M0 and the Opt-M0 were synthesized by using ACQb800 and ACQb1000 sets from the external testing dataset. For comparison, traditional calculated (b =1500 sec/mm2) DWI (CALb1500) sets were also obtained. Reader ratings for image quality and prostate cancer detection were performed on the acquired high-b-value (b = 1500 sec/mm2) DWI (ACQb1500), CALb1500, and SYNb1500 sets and the SYNb1500 set generated by the Opt-M0 (Opt-SYNb1500). Wilcoxon signed rank tests were used to compare the readers' scores. A multiple-reader multiple-case receiver operating characteristic curve was used to compare the diagnostic utility of each DWI set.
RESULTS: When compared with the Mcyc, the M0 yielded a lower mean squared difference and higher mean scores for the peak signal-to-noise ratio, structural similarity, and feature similarity (P < .001 for all). Opt-SYNb1500 resulted in significantly better image quality (P ≤ .001 for all) and a higher mean area under the curve than ACQb1500 and CALb1500 (P ≤ .042 for all).
CONCLUSION: A deep learning framework based on GAN is a promising method to synthesize realistic high-b-value DWI sets with good image quality and accuracy in prostate cancer detection.Keywords: Prostate Cancer, Abdomen/GI, Diffusion-weighted Imaging, Deep Learning Framework, High b Value, Generative Adversarial Networks© RSNA, 2021 Supplemental material is available for this article. 2021 by the Radiological Society of North America, Inc.

Entities:  

Keywords:  Abdomen/GI; Deep Learning Framework; Diffusion-weighted Imaging; Generative Adversarial Networks; High b Value; Prostate Cancer

Year:  2021        PMID: 34617025      PMCID: PMC8489442          DOI: 10.1148/ryai.2021200237

Source DB:  PubMed          Journal:  Radiol Artif Intell        ISSN: 2638-6100


  26 in total

1.  Motion correction and registration of high b-value diffusion weighted images.

Authors:  Shani Ben-Amitay; Derek K Jones; Yaniv Assaf
Journal:  Magn Reson Med       Date:  2011-12-19       Impact factor: 4.668

2.  Ultra-high-b-value diffusion-weighted MR imaging for the detection of prostate cancer: evaluation in 201 cases with histopathological correlation.

Authors:  Kazuhiro Katahira; Taro Takahara; Thomas C Kwee; Seitaro Oda; Yasuko Suzuki; Shoji Morishita; Kosuke Kitani; Yasuyuki Hamada; Mitsuhiko Kitaoka; Yasuyuki Yamashita
Journal:  Eur Radiol       Date:  2010-07-18       Impact factor: 5.315

3.  Diffusion-weighted MRI of the prostate: advantages of Zoomed EPI with parallel-transmit-accelerated 2D-selective excitation imaging.

Authors:  Kolja M Thierfelder; Michael K Scherr; Mike Notohamiprodjo; Jakob Weiß; Olaf Dietrich; Ullrich G Mueller-Lisse; Josef Pfeuffer; Konstantin Nikolaou; Daniel Theisen
Journal:  Eur Radiol       Date:  2014-08-27       Impact factor: 5.315

4.  Computed diffusion-weighted imaging of the prostate at 3 T: impact on image quality and tumour detection.

Authors:  Andrew B Rosenkrantz; Hersh Chandarana; Nicole Hindman; Fang-Ming Deng; James S Babb; Samir S Taneja; Christian Geppert
Journal:  Eur Radiol       Date:  2013-06-12       Impact factor: 5.315

5.  Computed diffusion-weighted MRI for prostate cancer detection: the influence of the combinations of b-values.

Authors:  Y Ueno; S Takahashi; Y Ohno; K Kitajima; M Yui; Y Kassai; F Kawakami; H Miyake; K Sugimura
Journal:  Br J Radiol       Date:  2015-01-21       Impact factor: 3.039

Review 6.  Whole-body diffusion-weighted MRI: tips, tricks, and pitfalls.

Authors:  Dow-Mu Koh; Matthew Blackledge; Anwar R Padhani; Taro Takahara; Thomas C Kwee; Martin O Leach; David J Collins
Journal:  AJR Am J Roentgenol       Date:  2012-08       Impact factor: 3.959

7.  Zoomed echo-planar imaging using parallel transmission: impact on image quality of diffusion-weighted imaging of the prostate at 3T.

Authors:  Andrew B Rosenkrantz; Hersh Chandarana; Josef Pfeuffer; Michael J Triolo; Mohammed Bilal Shaikh; David J Mossa; Christian Geppert
Journal:  Abdom Imaging       Date:  2015-01

8.  Quantitative investigative analysis of tumour separability in the prostate gland using ultra-high b-value computed diffusion imaging.

Authors:  Jeffrey Glaister; Andrew Cameron; Alexander Wong; Masoom A Haider
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2012

9.  Spine Computed Tomography to Magnetic Resonance Image Synthesis Using Generative Adversarial Networks : A Preliminary Study.

Authors:  Jung Hwan Lee; In Ho Han; Dong Hwan Kim; Seunghan Yu; In Sook Lee; You Seon Song; Seongsu Joo; Cheng-Bin Jin; Hakil Kim
Journal:  J Korean Neurosurg Soc       Date:  2020-01-14

10.  Reduced Field-of-View Diffusion-Weighted Magnetic Resonance Imaging of the Pancreas: Comparison with Conventional Single-Shot Echo-Planar Imaging.

Authors:  Hyungjin Kim; Jeong Min Lee; Jeong Hee Yoon; Jin-Young Jang; Sun-Whe Kim; Ji Kon Ryu; Stephan Kannengiesser; Joon Koo Han; Byung Ihn Choi
Journal:  Korean J Radiol       Date:  2015-10-26       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.